House committee grills Emergent CEO Bob Kramer over J&J vaccine debacle, ill-timed stock sale

With Maryland CDMO Emergent BioSolutions still holding formation as the FDA mulls over operations at its Bayview Baltimore plant, CEO Bob Kramer has been hammered for sending mixed messages on the screwup that led to the inspection in the first place. House leaders had some questions for him about that Wednesday — and it wasn’t pretty.